Although early work has reported the potential correlation between PEBP1 and the clinicopathological characteristics of cRCC patients [34–36], the function and metabolism of PEBP1 protein remain unknown during cRCC progression. This evidence concerns the gene PEBP1 and chromophobe renal cell carcinoma.